Clinical Trial Update: Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)

View source ↗

Summary

A completed clinical trial evaluating the influence of dalteparin in patients with renal insufficiency (DIRECT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Dalteparin (Fragmin) (dalteparin sodium)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Renal Insufficiency | Status: COMPLETED